Krane Funds Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $392K | Sell |
|
|||||
|
2025
Q2 | $437K | Buy |
|
|||||
|
2025
Q1 | $493K | Sell |
|
|||||
|
2024
Q4 | $514K | Sell |
|
|||||
|
2024
Q3 | $556K | Buy |
|
|||||
|
2024
Q2 | $412K | Sell |
|
|||||
|
2024
Q1 | $550K | Buy |
|
|||||
|
2023
Q4 | $276K | Sell |
|
|||||
|
2023
Q3 | $564K | Buy |
|
|||||
|
2023
Q2 | $571K | Buy |
|
|||||
|
2023
Q1 | $609K | Sell |
|
|||||
|
2022
Q4 | $639K | Sell |
|
|||||
|
2022
Q3 | $737K | Sell |
|
|||||
|
2022
Q2 | $807K | Sell |
|
|||||
|
2022
Q1 | $992K | Buy |
|
|||||
|
2021
Q4 | $402K | Sell |
|
|||||
|
2021
Q3 | $430K | Sell |
|
|||||
|
2021
Q2 | $1.18M | Buy |
|
|||||
|
2021
Q1 | $378K | Sell |
|
|||||
|
2020
Q4 | $656K | Buy |
|
|||||
|
2020
Q3 | $391K | Sell |
|
|||||
|
2020
Q2 | $391K | Sell |
|
|||||
|
2020
Q1 | $453K | Sell |
|
|||||
|
2019
Q4 | $570K | Buy |
|